| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
GeNeuro SA (PA: GNRO)
GNRO Technical Analysis
5
| As on 21st Nov 2024 GNRO STOCK Price closed @ 0.06 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.35 & Strong Sell for SHORT-TERM with Stoploss of 1.64 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GNROSTOCK Price
| Open | 0.06 | Change | Price | % |
| High | 0.06 | 1 Day | -0.01 | -14.29 |
| Low | 0.06 | 1 Week | -0.02 | -25.00 |
| Close | 0.06 | 1 Month | -0.03 | -33.33 |
| Volume | 10460 | 1 Year | -1.62 | -96.43 |
| 52 Week High 2.25 | 52 Week Low 0.06 | ||||
PA France Most Active Stocks
| ALNEV | 0.00 | % |
| FTI | 5.91 | -1.66% |
| VIEDS | 0.72 | 4.35% |
| ALVER | 0.00 | % |
| ATO | 0.16 | -15.79% |
| ALMAS | 0.01 | 0.00% |
| CGG | 0.69 | -2.82% |
| ALDRV | 0.00 | % |
| ELIOR | 2.75 | -11.86% |
| ALHYG | 0.01 | 0.00% |
PA France Top Gainers Stocks
PA France Top Losers Stocks
| GNRO Daily Charts |
GNRO Intraday Charts |
Whats New @ Bazaartrend |
GNRO Free Analysis |
|
|
GNRO Important Levels Intraday
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
GNRO Forecast November 2024
| 4th UP Forecast | 0.54 |
| 3rd UP Forecast | 0.39 |
| 2nd UP Forecast | 0.29 |
| 1st UP Forecast | 0.2 |
| 1st DOWN Forecast | -0.08 |
| 2nd DOWN Forecast | -0.17 |
| 3rd DOWN Forecast | -0.27 |
| 4th DOWN Forecast | -0.42 |
GNRO Weekly Forecast
| 4th UP Forecast | 0.16 |
| 3rd UP Forecast | 0.13 |
| 2nd UP Forecast | 0.11 |
| 1st UP Forecast | 0.09 |
| 1st DOWN Forecast | 0.03 |
| 2nd DOWN Forecast | 0.01 |
| 3rd DOWN Forecast | -0.01 |
| 4th DOWN Forecast | -0.04 |
GNRO Forecast2024
| 4th UP Forecast | 4.47 |
| 3rd UP Forecast | 3.06 |
| 2nd UP Forecast | 2.18 |
| 1st UP Forecast | 1.31 |
| 1st DOWN Forecast | -1.19 |
| 2nd DOWN Forecast | -2.06 |
| 3rd DOWN Forecast | -2.94 |
| 4th DOWN Forecast | -4.35 |
GeNeuro SA ( PA France Symbol : GNRO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GNRO Business Profile
GeNeuro SA, a clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases. The company's lead therapeutic candidate is temelimab, a monoclonal antibody, which has completed Phase IIb clinical trial for multiple sclerosis; and is in Phase IIa to treat type 1 diabetes, as well as is in Phase I for the treatment of chronic inflammatory demyelinating polyneuropathy. It has cooperative research and development agreements with The National Institute of Neurological Disorders and Stroke to develop novel therapeutic antibodies for the treatment of amyotrophic lateral sclerosis; and Academic labs to develop inflammatory psychosis, as well as a research collaboration agreement with International Center for Infectiology Research; and with Northwestern University for human endogenous retrovirus W envelope protein (HERV-W ENV) in long-haul COVID patients. The company was incorporated in 2006 and is headquartered in Plan-les-Ouates, Switzerland. Address: 3 chemin du PrE-Fleuri, Plan-les-Ouates, Switzerland, 1228
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service